This year, the Food and Drug Administration announced it was taking steps to help gene therapies gain accelerated approval. Throughout 2022, the FDA approved three new gene therapy treatments for adult patients with various health issues including bladder cancer, Hemophilia B and more.

In April, scientists at Trinity College Dublin announced a significant development towards a new therapeutic treatment of glaucoma.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.